Conditional deletion of TGF-βR1 using Langerin-Cre mice results in Langerhans cell deficiency and reduced contact hypersensitivity

Journal of Immunology

Volumn 187, Issue 10, 2011, Pages 5069-5076

  Zahner, Sonja P ^a,b   Kel, Junda M ^a   Martina, Cerithsa A E ^b   Brouwers Haspels, Inge ^a   Van Roon, Marian A ^c   Clausen, Bjor̈n E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; LANGERIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; DENDRITIC CELL; DNA RECOMBINATION; EAR; EMBRYO; GENE DELETION; GENE TARGETING; HOMOZYGOTE; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; SWELLING;

ANIMALS; ANTIGENS, CD; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; DISEASE MODELS, ANIMAL; GENE DELETION; GENE EXPRESSION REGULATION; GENE KNOCK-IN TECHNIQUES; GENE TARGETING; INTEGRASES; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 81455154983     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101880     Document Type: Article

References (49)

1. Romani, N., B. E. Clausen, and P. Stoitzner. 2010. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol. Rev. 234: 120-141.
2. Nishibu, A., B. R. Ward, J. V. Jester, H. L. Ploegh, M. Boes, and A. Takashima. 2006. Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J. Invest. Dermatol. 126: 787-796.
3. Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12: 71-81. (Pubitemid 30069216)
4. Takahara, K., Y. Omatsu, Y. Yashima, Y. Maeda, S. Tanaka, T. Iyoda, B. E. Clausen, K. Matsubara, J. Letterio, R. M. Steinman, et al. 2002. Identification and expression of mouse Langerin (CD207) in dendritic cells. [Published erratum appears in 2002 Int. Immunol. 14: 831.] Int. Immunol. 14: 433-444. (Pubitemid 34521066)
5. Poulin, L. F., S. Henri, B. de Bovis, E. Devilard, A. Kissenpfennig, and B. Malissen. 2007. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204: 3119-3131.
6. Ginhoux, F., M. P. Collin, M. Bogunovic, M. Abel, M. Leboeuf, J. Helft, J. Ochando, A. Kissenpfennig, B. Malissen, M. Grisotto, et al. 2007. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204: 3133-3146.
7. Bursch, L. S., L.Wang, B. Igyarto, A. Kissenpfennig, B. Malissen, D. H. Kaplan, and K. A. Hogquist. 2007. Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 204: 3147-3156.
8. Nagao, K., F. Ginhoux, W. W. Leitner, S. Motegi, C. L. Bennett, B. E. Clausen, M. Merad, and M. C. Udey. 2009. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl. Acad. Sci. USA 106: 3312-3317.
9. Henri, S., L. F. Poulin, S. Tamoutounour, L. Ardouin, M. Guilliams, B. de Bovis, E. Devilard, C. Viret, H. Azukizawa, A. Kissenpfennig, and B. Malissen. 2010. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207: 189-206.
10. Borkowski, T. A., J. J. Letterio, A. G. Farr, and M. C. Udey. 1996. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184: 2417-2422. (Pubitemid 27023742)
11. Kel, J. M., M. J. Girard-Madoux, B. Reizis, and B. E. Clausen. 2010. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis. J. Immunol. 185: 3248-3255.
12. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654. (Pubitemid 40719199)
13. Clausen, B. E., and J. M. Kel. 2010. Langerhans cells: critical regulators of skin immunity? Immunol. Cell Biol. 88: 351-360.
14. Sung, S. S., S. M. Fu, C. E. Rose, Jr., F. Gaskin, S. T. Ju, and S. R. Beaty. 2006. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176: 2161-2172. (Pubitemid 43201663)
15. Edelson, B. T., W. Kc, R. Juang, M. Kohyama, L. A. Benoit, P. A. Klekotka, C. Moon, J. C. Albring, W. Ise, D. G. Michael, et al. 2010. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 207: 823-836.
16. Ginhoux, F., K. Liu, J. Helft, M. Bogunovic, M. Greter, D. Hashimoto, J. Price, N. Yin, J. Bromberg, S. A. Lira, et al. 2009. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206: 3115-3130.
17. Kautz-Neu, K., M. Noordegraaf, S. Dinges, C. L. Bennett, D. John, B. E. Clausen, and E. von Stebut. 2011. Langerhans cells are negative regulators of the anti-Leishmania response. J. Exp. Med. 208: 885-891.
18. Schwarz, A., M. Noordegraaf, A. Maeda, K. Torii, B. E. Clausen, and T. Schwarz. 2010. Langerhans cells are required for UVR-induced immunosuppression. J. Invest. Dermatol. 130: 1419-1427.
19. Yoshiki, R., K. Kabashima, J. Sakabe, K. Sugita, T. Bito, M. Nakamura, B. Malissen, and Y. Tokura. 2010. The mandatory role of IL-10-producing and OX40 ligand-expressing mature Langerhans cells in local UVB-induced immunosuppression. J. Immunol. 184: 5670-5677.
20. Wang, L., S. C. Jameson, and K. A. Hogquist. 2009. Epidermal Langerhans cells are not required for UV-induced immunosuppression. J. Immunol. 183: 5548-5553.
21. Bedoui, S., P. G. Whitney, J. Waithman, L. Eidsmo, L. Wakim, I. Caminschi, R. S. Allan, M. Wojtasiak, K. Shortman, F. R. Carbone, et al. 2009. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 10: 488-495.
22. den Haan, J. M., S. M. Lehar, and M. J. Bevan. 2000. CD8(+) but not CD8(2) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192: 1685-1696.
23. GeurtsvanKessel, C. H., M. A. Willart, L. S. van Rijt, F. Muskens, M. Kool, C. Baas, K. Thielemans, C. Bennett, B. E. Clausen, H. C. Hoogsteden, et al. 2008. Clearance of influenza virus from the lung depends on migratory langerin+ CD11b2 but not plasmacytoid dendritic cells. J. Exp. Med. 205: 1621-1634.
24. Ortiz-Stern, A., A. Kanda, C. Mionnet, J. Cazareth, A. Lazzari, S. Fleury, D. Dombrowicz, N. Glaichenhaus, and V. Julia. 2011. Langerin+ dendritic cells are responsible for LPS-induced reactivation of allergen-specific Th2 responses in postasthmatic mice. Mucosal Immunol. 4: 343-353.
25. Vocanson, M., A. Hennino, A. Rozières, G. Poyet, and J. F. Nicolas. 2009. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64: 1699-1714.
26. Gorbachev, A. V., and R. L. Fairchild. 2004. CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J. Immunol. 172: 2286-2295. (Pubitemid 38182376)
27. Toews, G. B., P. R. Bergstresser, and J. W. Streilein. 1980. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124: 445-453. (Pubitemid 10182298)
28. Bennett, C. L., E. van Rijn, S. Jung, K. Inaba, R. M. Steinman, M. L. Kapsenberg, and B. E. Clausen. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169: 569-576. (Pubitemid 41002850)
29. Noordegraaf, M., V. Flacher, P. Stoitzner, and B. E. Clausen. 2010. Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. J. Invest. Dermatol. 130: 2752-2759.
30. Honda, T., S. Nakajima, G. Egawa, K. Ogasawara, B. Malissen, Y. Miyachi, and K. Kabashima. 2010. Compensatory role of Langerhans cells and langerin-positive dermal dendritic cells in the sensitization phase of murine contact hypersensitivity. J. Allergy Clin. Immunol. 125: 1154-1156.e2.
31. Kaplan, D. H., M. C. Jenison, S. Saeland, W. D. Shlomchik, and M. J. Shlomchik. 2005. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-620. (Pubitemid 41779483)
32. Ohnmacht, C., A. Pullner, S. B. King, I. Drexler, S. Meier, T. Brocker, and D. Voehringer. 2009. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206: 549-559.
33. Bobr, A., I. Olvera-Gomez, B. Z. Igyarto, K. M. Haley, K. A. Hogquist, and D. H. Kaplan. 2010. Acute ablation of Langerhans cells enhances skin immune responses. J. Immunol. 185: 4724-4728.
34. Luche, H., O. Weber, T. Nageswara Rao, C. Blum, and H. J. Fehling. 2007. Faithful activation of an extra-bright red fluorescent protein in "knock-in" Crereporter mice ideally suited for lineage tracing studies. Eur. J. Immunol. 37: 43-53. (Pubitemid 46128785)
35. Larsson, J., M. J. Goumans, L. J. Sjöstrand, M. A. van Rooijen, D. Ward, P. Levéen, X. Xu, P. ten Dijke, C. L. Mummery, and S. Karlsson. 2001. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 20: 1663-1673. (Pubitemid 32299403)
36. Gu, H., Y. R. Zou, and K. Rajewsky. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73: 1155-1164. (Pubitemid 23180489)
37. Eggan, K., H. Akutsu, J. Loring, L. Jackson-Grusby, M. Klemm, W. M. Rideout, III, R. Yanagimachi, and R. Jaenisch. 2001. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. USA 98: 6209-6214. (Pubitemid 32488218)
38. Rodríguez, C. I., F. Buchholz, J. Galloway, R. Sequerra, J. Kasper, R. Ayala, A. F. Stewart, and S. M. Dymecki. 2000. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25: 139-140. (Pubitemid 30394979)
39. Rajewsky, K., H. Gu, R. Kühn, U. A. Betz, W. Müller, J. Roes, and F. Schwenk. 1996. Conditional gene targeting. J. Clin. Invest. 98: 600-603. (Pubitemid 26349161)
40. Kissenpfennig, A., S. Aït-Yahia, V. Clair-Moninot, H. Stössel, E. Badell, Y. Bordat, J. L. Pooley, T. Lang, E. Prina, I. Coste, et al. 2005. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol. Cell. Biol. 25: 88-99. (Pubitemid 40039802)
41. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161: 526-546. (Pubitemid 15142803)
42. Wilson, N. S., and J. A. Villadangos. 2004. Lymphoid organ dendritic cells: beyond the Langerhans cells paradigm. Immunol. Cell Biol. 82: 91-98. (Pubitemid 38388725)
43. Valladeau, J., V. Clair-Moninot, C. Dezutter-Dambuyant, J. J. Pin, A. Kissenpfennig, M. G. Matteí, S. Ait-Yahia, E. E. Bates, B. Malissen, F. Koch, et al. 2002. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J. Immunol. 168: 782-792. (Pubitemid 34049579)
44. Henri, S., M. Guilliams, L. F. Poulin, S. Tamoutounour, L. Ardouin, M. Dalod, and B. Malissen. 2010. Disentangling the complexity of the skin dendritic cell network. Immunol. Cell Biol. 88: 366-375.
45. Flacher, V., P. Douillard, S. Aït-Yahia, P. Stoitzner, V. Clair-Moninot, N. Romani, and S. Saeland. 2008. Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains. Immunology 123: 339-347. (Pubitemid 351171198)
46. Kaplan, D. H., A. Kissenpfennig, and B. E. Clausen. 2008. Insights into Langerhans cell function from Langerhans cell ablation models. Eur. J. Immunol. 38: 2369-2376.
47. Caton, M. L., M. R. Smith-Raska, and B. Reizis. 2007. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204: 1653-1664. (Pubitemid 47048031)
48. Kaplan, D. H., M. O. Li, M. C. Jenison, W. D. Shlomchik, R. A. Flavell, and M. J. Shlomchik. 2007. Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J. Exp. Med. 204: 2545-2552. (Pubitemid 350044780)
49. Bennett, C. L., M. Noordegraaf, C. A. Martina, and B. E. Clausen. 2007. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J. Immunol. 179: 6830-6835